In sharp contrast, the SBU-CD55 × CD20 antibody exhibited dramatically improved tumor cell clearance of 91.42% and 83.21% in the Ramos and WSU-NHL cells, respectively (Fig. 4c,d). Here, CD55 is linked to non-Hodgkin lymphoma.